30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Nextremity Solutions Gains FDA Clearance For Lapidus Procedure -

Nextremity Solutions received FDA 510(k) clearance to market the InCore™ Lapidus system for fusion of the first tarsometatarsal joint. InCore Lapidus is a three-part construct intended for internal fixation for First Metatarsocuneiform Arthrodesis. An application is pending for CE Mark approval. (Nextremity Solutions Inc., 5/4/18)